Stock listing

VIR Stock Price, News, Filings & Events — Vir Biotechnology, Inc.

Selected listing: VIR · BOATS · USD · US

This page tracks Vir Biotechnology, Inc.'s VIR:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VIR:BOATS. VIR:BOATS is the stock-level entry point for investors researching Vir Biotechnology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vir Biotechnology, Inc. is a public company traded under the ticker VIR in the American market. The company has a market capitalization of approximately $1.59 billion. Vir focuses on developing innovative therapies for infectious diseases.

VIR:BOATSUSDUSUpdated July 24, 2026
Vir Biotechnology, Inc. logo
Ticker
VIR:BOATS
Asset type
Stock
Market cap
$1.47B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Vir Biotechnology, Inc. VIR:BOATS stock context

This page tracks Vir Biotechnology, Inc.'s VIR:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VIR:BOATS. VIR:BOATS is the stock-level entry point for investors researching Vir Biotechnology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vir Biotechnology, Inc. is a public company traded under the ticker VIR in the American market. The company has a market capitalization of approximately $1.59 billion. Vir focuses on developing innovative therapies for infectious diseases.

Research Vir Biotechnology, Inc.

Alternate listings